Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Karoline V. Gleixner

CDK4/CDK6 Inhibition as a Novel Strategy to Suppress the Growth and Survival of BCR-ABL1T315I+ Clones in TKI-resistant CML

Molecular Biology

English

Related publications

Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML

Cancer Research

Molecular Biology

English

Coexistence of AML1/RUNX1 and BCR-ABL Point Mutations in an Imatinib-Resistant Form of CML

Cancer Research

English

Ectopic Expression of Cdk6 Circumvents Transforming Growth Factor-Β Mediated Growth Inhibition

Cancer Research

Molecular Biology

English

Adherence to BCR-ABL Inhibitors: Issues for CML Therapy

Clinical Lymphoma, Myeloma and Leukemia

Cancer Research

English

The Chimeric Ubiquitin Ligase SH2-U-box Inhibits the Growth of Imatinib-Sensitive and Resistant CML by Targeting the Native and T315i-Mutant BCR-ABL

Scientific Reports

Multidisciplinary

English

BCR-ABLT315I Transcript Disappearance in an Imatinib-Resistant CML Patient Treated With Homoharringtonine: A New Therapeutic Challenge?

Cancer Research

English

Downregulation of Γ-Catenin Inhibits CML Cell Growth and Potentiates the Response of CML Cells to Imatinib Through Β-Catenin Inhibition

International Journal of Molecular Medicine

English

Selective JAK2/ABL Dual Inhibition Therapy Effectively Eliminates TKI-insensitive CML Stem/Progenitor Cells

English

A Novel BCR-Abl Splice Isoform Is Associated With the L248V Mutation in CML Patients With Acquired Resistance to Imatinib

Cancer Research

English